Results 11 to 20 of about 844,715 (299)

Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy. [PDF]

open access: yes, 2002
In part A of this study, patients were randomised to cohorts receiving darbepoetin alfa at doses of 0.5 to 8.0 m.c.g x kg(-1) x wk(-1) or to a control group receiving epoetin alfa at an initial dose of 150 U x kg(-1) three times weekly.
Armstrong, S   +10 more
core   +2 more sources

Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer : randomized clinical trial [PDF]

open access: yes, 2013
BACKGROUND: The AGO-ETC trial compared 5-year relapse-free survival of intense dose-dense (IDD) sequential chemotherapy with epirubicin (E), paclitaxel (T), and cyclophosphamide (C) (IDD-ETC) every 2 weeks vs conventional scheduled epirubicin ...
Bois, Andreas du   +13 more
core   +1 more source

Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase. [PDF]

open access: yes, 2016
Taliglucerase alfa is the first available plant cell-expressed human recombinant therapeutic protein. It is indicated for treatment of patients with type 1 Gaucher disease (GD) in adult and pediatric patients in several countries.
Amato, Dominick J   +9 more
core   +2 more sources

Cloning and expression of codon-optimized recombinant darbepoetin alfa in Leishmania tarentolae T7-TR [PDF]

open access: yes, 2016
Darbepoetin alfa is an engineered and hyperglycosylated analog of recombinant human erythropoietin (EPO) which is used as a drug in treating anemia in patients with chronic kidney failure and cancer.
Fard-Esfahani, P.   +8 more
core   +1 more source

Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort [PDF]

open access: yes, 2016
BACKGROUND: Despite the introduction of direct-acting antiviral agents for chronic hepatitis C virus (HCV) infection, peginterferon alfa/ribavirin remains relevant in many resource-constrained settings.
Abbas, Zaigham   +303 more
core   +1 more source

Editorial [PDF]

open access: yesArchitecture Papers of the Faculty of Architecture and Design STU, 2021
prof. Dr. Henri Hubertus Achten
doaj   +3 more sources

Effect of Alkali Treatment on Alfa Fibers Behavior

open access: yesJournal of Natural Fibers, 2017
The object of this study is to characterize of Algerian Alfa (Esparto grass or Stipa tenacissima L), and also to examine the effect of chemical treatment on different properties of this fiber.
S. Mouhoubi   +3 more
doaj   +1 more source

In pursuit of β-amino α-nitro β-trifluoromethyl ketones: nitro-Mannich vs Mannich-type reactions [PDF]

open access: yes, 2017
The reactivity of alfa-nitro ketones with trifluoromethyl aldimines is studied for the first time. While under nitro-Mannich conditions only the facial stereoselectivity can be controlled, organocatalysed Mannich-type reactions allowed a complete control
Ballini   +45 more
core   +1 more source

Epoetin alfa increases frataxin production in Friedreich's ataxia without affecting hematocrit. [PDF]

open access: yes, 2011
Objective of the study was to test the efficacy, safety, and tolerability of two single doses of Epoetin alfa in patients with Friedreich's ataxia. Ten patients were treated subcutaneously with 600 IU/kg for the first dose, and 3 months later with 1200 ...
ACQUAVIVA, Fabio   +13 more
core   +1 more source

PROTECTION OF YIELD AND SOIL: NEW MULCHING TECHNOLOGY

open access: yesОвощи России, 2016
Biodegradable ecovio® plastic films for mulching is a solution of BASF engineering.It offers the excellent mechanical properties, and it is completely destructedas polymer is to be fully composted.
N. V. Sorokina, L. A. Uzhaninova
doaj   +1 more source

Home - About - Disclaimer - Privacy